000 | 01649 a2200505 4500 | ||
---|---|---|---|
005 | 20250513133354.0 | ||
264 | 0 | _c19980205 | |
008 | 199802s 0 0 eng d | ||
022 | _a0161-5505 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMinn, H | |
245 | 0 | 0 |
_aPrediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer. _h[electronic resource] |
260 |
_bJournal of nuclear medicine : official publication, Society of Nuclear Medicine _cDec 1997 |
||
300 |
_a1907-11 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdiagnostic imaging |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFluorine Radioisotopes |
650 | 0 | 4 | _aFluorodeoxyglucose F18 |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aHead and Neck Neoplasms _xdiagnostic imaging |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMultivariate Analysis |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aRadiopharmaceuticals |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTomography, Emission-Computed |
700 | 1 | _aLapela, M | |
700 | 1 | _aKlemi, P J | |
700 | 1 | _aGrénman, R | |
700 | 1 | _aLeskinen, S | |
700 | 1 | _aLindholm, P | |
700 | 1 | _aBergman, J | |
700 | 1 | _aEronen, E | |
700 | 1 | _aHaaparanta, M | |
700 | 1 | _aJoensuu, H | |
773 | 0 |
_tJournal of nuclear medicine : official publication, Society of Nuclear Medicine _gvol. 38 _gno. 12 _gp. 1907-11 |
|
999 |
_c9399876 _d9399876 |